Your browser doesn't support javascript.
loading
Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction.
Hertoghs, Nina; Nijmeijer, Bernadien M; van Teijlingen, Nienke H; Fenton-May, Angharad E; Kaptein, Tanja M; van Hamme, John L; Kappes, John C; Kootstra, Neeltje A; Hahn, Beatrice H; Borrow, Persephone; Ribeiro, Carla M S; Geijtenbeek, Teunis B H.
Afiliación
  • Hertoghs N; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Nijmeijer BM; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • van Teijlingen NH; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Fenton-May AE; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Kaptein TM; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • van Hamme JL; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Kappes JC; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States of America.
  • Kootstra NA; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Hahn BH; Departments of Medicine and Microbiology, University of Pennsylvania, Philadelphia, PA, United States of America.
  • Borrow P; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Ribeiro CMS; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
  • Geijtenbeek TBH; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
PLoS One ; 14(12): e0226651, 2019.
Article en En | MEDLINE | ID: mdl-31856198
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células de Langerhans / VIH-1 / Interacciones Huésped-Patógeno Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células de Langerhans / VIH-1 / Interacciones Huésped-Patógeno Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos